Bangladesh - englanti - DGDA (Directorate General of Drug Administration)

techno drugs ltd. - pyrimethamine + sulfaquinoxaline sodium - oral solution - 15 gm + 50 gm/100 ml

Belgia - englanti - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glaxosmithkline pharmaceuticals sa-nv - pyrimethamine 25 mg - tablet - 25 mg - pyrimethamine 25 mg - pyrimethamine

Bangladesh - englanti - DGDA (Directorate General of Drug Administration)

edcl (dhaka) - pyrimethamine + sulfadoxine - tablet - 25 mg + 500 mg

Kenia - englanti - Pharmacy and Poisons Board

biodeal laboratories ltd 32040-00600 nairobi - pyrimethamine and sulfadoxine - syrup - pyrimethamine 12.5mg and sulfadoxine 250mg per 5ml - antimalarial antiprotozoals: diaminopyrimidines

Kenia - englanti - Pharmacy and Poisons Board

biodeal laboratories ltd 32040-00600 nairobi - pyrimethamine and sulphadoxine - tablet - pyrimethamine 25mg and sulphadoxine 500mg per… - antimalarial antiprotozoals: diaminopyrimidines

Kanada - englanti - Health Canada

amedra pharmaceuticals llc - pyrimethamine - tablet - 25mg - pyrimethamine 25mg - antimalarials

Yhdysvallat - englanti - NLM (National Library of Medicine)

pegasus laboratories, inc - sulfadiazine sodium (unii: 84cs1p306f) (sulfadiazine - unii:0n7609k889), pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - sulfadiazine 250 mg in 1 ml - rebalance antiprotozoal oral suspension is indicated for the treatment of horses with equine protozoal myeloencephalitis (epm) caused by sarcocystis neurona . the use of rebalance antiprotozoal oral suspension in contraindicated in horses with known hypersensitivity to sulfonamide drugs or pyrimethamine.

Yhdysvallat - englanti - NLM (National Library of Medicine)

tilde sciences llc - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: daraprim is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of daraprim is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

Tansania - englanti - Tanzania Medicinces & Medical Devices Authority

shanghai fosun pharmaceutical industrial development co., ltd, china - sulfadoxine/pyrimethamine/amodiaquine (as hydrochloride) - dispersible tablets - 500/25

Tansania - englanti - Tanzania Medicinces & Medical Devices Authority

shanghai fosun pharmaceutical industrial development co., ltd, china - sulfadoxine/pyrimethamine/amodiaquine (as hydrochloride) - dispersible tablets - 250/12.5/76.5